Variation rs2235503 C > A Within the Promoter of MSLN Affects Transcriptional Rate of Mesothelin and Plasmatic Levels of the Soluble Mesothelin-Related Peptide
Soluble mesothelin-related peptide (SMRP) is a promising biomarker for malignant pleural mesothelioma (MPM), but several confounding factors can reduce SMRP-based test’s accuracy. The identification of these confounders could improve the diagnostic performance of SMRP. In this study, we evaluated th...
Main Authors: | Roberto Silvestri, Perla Pucci, Chiara De Santi, Irene Dell’Anno, Simona Miglietta, Alda Corrado, Vanessa Nicolí, Daniela Marolda, Monica Cipollini, Enrica Pellegrino, Monica Evangelista, Alessandra Bonotti, Rudy Foddis, Alfonso Cristaudo, Stefano Landi, Federica Gemignani |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2020.00975/full |
Similar Items
-
Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases
by: Goricar Katja, et al.
Published: (2020-03-01) -
The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors
by: Yu Yi, et al.
Published: (2011-07-01) -
Mesothelin as a biomarker for targeted therapy
by: Jiang Lv, et al.
Published: (2019-08-01) -
Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors
by: Brendan L. Hagerty, et al.
Published: (2020-06-01) -
Mesothelin Expression in Gastric Adenocarcinoma and Its Relation to Clinical Outcomes
by: Song-Hee Han, et al.
Published: (2017-03-01)